Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation by negative crosstalk

被引:0
|
作者
Horiuchi, M [1 ]
Hayashida, W [1 ]
Akishita, M [1 ]
Tamura, K [1 ]
Daviet, L [1 ]
Lehtonen, JYA [1 ]
Dzau, VJ [1 ]
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA
关键词
angiotensin; receptor; STAT; vascular smooth muscle cell;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiotensin II type 2 (AT(2)) receptor exerts an inhibitory action on cell growth. In the present study, we report that the Stimulation of AT(2) receptor in AT(2) receptor cDNA-transfected mt-adult vascular smooth muscle cells (VSMCs) inhibited angiotensin II type 1 (AT(2)) receptor-mediated tyrosine phosphorylation of STAT (signal transducers and activators of transcription) 1 alpha/beta, STAT2, and STAT3 without influence on Janus kinase. AT(2) receptor activation also inhibited the tyrosine phosphorylation of STAT1 alpha/beta induced by interferon-gamma, epidermal growth factor, and platelet-derived growth factor. Similar effects of AT(2) receptor were observed in R3T3 fibroblast and mouse fetal VSMCs, which express endogenous AT(2) receptor. Moreover, AT(2) receptor inhibited serine:phosphorylation of STAT1 alpha and STAT3 via the inhibition of extracellular signal-regulated kinase (ERK) activation.: Stimulation of AT(2) receptor inhibited the binding of STATs with sis-inducing element in c-fos promoter, resulting:in decreased c-fos expression. Taken together, our results suggest that AT(2) receptor can crosstalk negatively with multiple families of growth receptors by inhibiting ERK and STAT activation.
引用
收藏
页码:876 / 882
页数:7
相关论文
共 50 条
  • [31] Functions of AT2 receptors of angiotensin II
    Heymes, C
    Levy, BI
    THERAPIE, 1998, 53 (03): : 213 - 216
  • [32] Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis
    O Arrieta
    B Pineda-Olvera
    P Guevara-Salazar
    N Hernández-Pedro
    D Morales-Espinosa
    T L Cerón-Lizarraga
    C H González-De la Rosa
    D Rembao
    B Segura-Pacheco
    J Sotelo
    British Journal of Cancer, 2008, 99 : 160 - 166
  • [33] Tissue localization of ACE and angiotensin AT1, AT2 and AT4 receptors
    Mendelsohn, FAO
    JOURNAL OF HYPERTENSION, 1998, 16 : S9 - S9
  • [34] Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors
    Bosnyak, Sanja
    Jones, Emma S.
    Christopoulos, Arthur
    Aguilar, Marie-Isabel
    Thomas, Walter G.
    Widdop, Robert E.
    CLINICAL SCIENCE, 2011, 121 (7-8) : 297 - 303
  • [35] Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodelling
    Zhu, YC
    Zhu, YZ
    Lu, N
    Wang, MJ
    Wang, YX
    Yao, T
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2003, 30 (12) : 911 - 918
  • [36] Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis
    Arrieta, O.
    Pineda-Olvera, B.
    Guevara-Salazar, P.
    Hernandez-Pedro, N.
    Morales-Espinosa, D.
    Ceron-Lizarraga, T. L.
    Gonzalez-De la Rosa, C. H.
    Rembao, D.
    Segura-Pacheco, B.
    Sotelo, J.
    BRITISH JOURNAL OF CANCER, 2008, 99 (01) : 160 - 166
  • [37] Roles of AT1 and AT2 receptors in atherogenesis
    Horiuchi, M
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : S239 - S239
  • [38] Angiotensin II activates nuclear transcription factor-κB through AT1 and AT2 receptors
    Wolf, G
    Wenzel, U
    Burns, KD
    Harris, RC
    Stahl, RAK
    Thaiss, F
    KIDNEY INTERNATIONAL, 2002, 61 (06) : 1986 - 1995
  • [39] Cancer, inflammation and the AT1 and AT2 receptors
    Smith G.R.
    Missailidis S.
    Journal of Inflammation, 1 (1)
  • [40] Pathophysiological and clinical implications of AT1 and AT2 angiotensin II receptors in metabolic disorders:: Hypercholesterolaemia and diabetes
    Strawn, WB
    DRUGS, 2002, 62 : 31 - 41